# K152542: Powder Free Nitrile Examination Glove (Blue) With Low Dermatitis Potential Claim and with tested for Use with Chemotherapy Drugs

- Pathway: 510(k) (Traditional)
- Applicant: Riverstone Resources Sdn Bhd
- Decided: Dec 24, 2015 after 111 days
- Product code: LZA (Polymer Patient Examination Glove)
- Device class: 1
- Regulation: 21 CFR 880.6250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K022765 (2002). 4 ancestors in all.
3 later devices descend from it; 2 cite it directly.
0 of 8 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K050122: Powder Free Nitrile Examination Glove (Blue) (This Product Does Not Contain Thiuram, and/or Carbamate and/or Thiazole), Smart Glove Corp. Sdn Bhd (2005) Summary page 6.
- K141623: Emg Blue Nitrile Medical Examination Glove with Chemotherapy Drug Labeling Claim, Eco Medi Glove Sdn. Bhd. (2014) Summary page 6.

## Most influential descendants
- K181066: Powder Free Nitrile Examination Glove (Blue) with Low Dermatitis claim and with tested for Use with Chemotherapy Drugs Claims (2018), 1 descendant of its own
- K233560: Powder Free Nitrile Examination Glove Blue with Low Dermatitis Potential Claim, Tested for use with Chemotherapy Drugs, Fentanyl and Gastric Acid (2024), 0 descendants of its own
- K193121: GEN 2 Nitrile Examination Glove (Blue) With Low Dermatitis Potential Claim and with tested for use with Chemotherapy Drugs Claims (2020), 0 descendants of its own

## Indications for use
The Nitrile Powder Free Examination Glove (Blue) with Low Dermatitis Potential Claim is a disposable device intended for Medical purpose that is worn on the examiner's hands or finger to prevent contamination patient and examiner In addition these gloves was tested for use with Chemotherapy drugs in accordance with ASTM D6978-05 standards, Practice for assessment of medical glove to Permeation by chemotherapy Drugs. Chemotherapy Drugs and Concentration Minimum Breakthrough Detection time in minutes,0.0 1 ug/cm2/minute 1)Carmustine (BCNU)(3.3mg/ml) 20.1 Minutes 2)Cyclophosphamide (20mg/ml) > 240 Minutes 3)Cisplatin (1.0mg/ml)(1000ppm) > 240 Minutes 4)Doxorubicin Hydrochloride (2 mg/ml) > 240 Minutes 5) Etoposide (20mg/ml) > 240 Minutes 6) Fuorouracil (50mg/ml) > 240 Minutes 7)Methorexate (25mg/ml) > 240 Minutes 8)Paclitaxel (6mg/ml) > 240 Minutes 9)Thiotepa (10mg/ml) 50.6 minutes The Maximum testing time is 240 minutes . Please note that the following drugs have low permeation time 1) Carmustine (BCNU)(3.3mg/ml) with Permeation time of 20.1 minutes 2) Thiotepa (10mg/ml) with Permeation time of 50.6 Minutes

Source page: https://510kreport.com/device/K152542
Methodology: https://510kreport.com/methodology